Head-to-head · WeighScore
NovoCare Pharmacy vs OlleveCare
The verdict
NovoCare Pharmacy takes it — 55.2/100 to 46.2/100.
NovoCare Pharmacy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NovoCare Pharmacy | OlleveCare |
|---|---|---|
| WeighScore | 55.2/100 | 46.2/100 |
| Grade | C | C |
| Scorecard rank | #442 | #497 |
| Semaglutide | $349/mo (2.4 mg dose, brand-name) | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | All 50 states | 13 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #442 · C
Strengths
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
Where it loses points
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Graded #497 · C
Strengths
- 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
- Both semaglutide and tirzepatide offered — switch molecules without switching platforms
- Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
- Cash-pay with a superbill option for out-of-network reimbursement
- Founder Ahmed Emam is named in the footer
Where it loses points
- Legal entity name not disclosed anywhere — can't be verified in a state registry
- Pricing not shown before booking — you must enter the intake flow to see the fee
- Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
- No medical director or prescribing clinician named — only 'board-certified providers'
- No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.